After further scrutiny, we also determined that the circadian gene Per2 might participate in NASH by promoting ferroptosis; moreover, ferroptosis likely promoted NASH by inhibiting the expression of PPARα. The gene discussed is PER2; the disease is metabolic dysfunction-associated steatohepatitis.